Abstract 1873P
Background
Patients living with myeloproliferative neoplasms (MPN), including myelofibrosis (MF), polycythaemia vera (PV) and essential thrombocythemia (ET), should engage in self-care behaviours to improve their health. This study aims to preliminary assess self-care behaviours in MPN patients.
Methods
A descriptive cross-sectional study has been conducted in 9 haematology centres in Italy since November 2021. The Italian Association of MPN Patients (AIPAMM) promoted this study. The Self-Care in MyeloProliferative Neoplasms Inventory (SC-MPNI), a 31-item questionnaire measuring self-care behaviours according to the Middle-Range Theory of Self-Care of Chronic Illness, was developed and tested for its content validity. MPN patients were asked to complete a paper-and-pencil questionnaire during their outpatient visit or at home.
Results
Preliminary data from 171 patients (54% male; mean age=58, SD=19) and 5 centres were analysed (45.6% of the expected sample). Participants were living with overt MF (n=51), prefibrotic MF (n=24), PV (n=48) or ET (n=44). Concerning self-care maintenance, the most frequent behaviour was attending all scheduled clinical appointments (M=5.9, SD=0.6), and the least used one was performing activities that improve mental and physical well-being (M=3.1, SD=1.7). Concerning self-care monitoring, the most frequent behaviour was getting blood tests as prescribed by the haematologist (M=5.9, SD=0.5), and the least used one was checking any measurement the healthcare providers recommend (M=4.7, SD=1.4). Concerning self-care management, the most frequent behaviour was accurately reporting symptoms to the healthcare providers during visits to get a comprehensive response (M=5.5, SD=0.9), and the least used one was asking for psychological support to overcome emotional problems (M=2.6, SD=1.5).
Conclusions
This study will contribute to assessing self-care behaviours in patients with MPN. Health professionals should support innovative interventions to promote self-care, which is crucial for MPN patients to reduce cardiovascular events and be medically fit to undergo hematopoietic stem cell transplantation.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1855P - Assessment of depression and anxiety among adult patients with solid tumours admitted in national institute of cancer research & hospital
Presenter: Salman Al Ayub
Session: Poster session 05
1857P - Psychological distress in Georgian cancer patients undergoing chemotherapy: Before and after the COVID-19 pandemic
Presenter: Mariam Abuladze
Session: Poster session 05
1858P - Discrepancies between psychological stress and emotional care in cancer patients revealed in a social listening analysis
Presenter: Dalyong Kim
Session: Poster session 05
1859P - Digital goal management training as treatment for cognitive impairment in cervical cancer survivors: A feasibility study
Presenter: Elisabeth Areklett
Session: Poster session 05
1860P - Objective and subjective neurocognitive functioning (NCF) in advanced cancer survivors treated with immune checkpoint blockade (ICB)
Presenter: Nathalie Vanlaer
Session: Poster session 05
1861P - A randomized controlled trial on the efficacy and safety of the Untire app for moderate-to-severe cancer-related fatigue in German patients
Presenter: Simon Spahrkäs
Session: Poster session 05
1862P - Measuring the prevalence of fatigue in children with cancer: Evidence from Egypt
Presenter: Nourhan Abdalkader
Session: Poster session 05
1863P - Compassion fatigue among the staff involved in medical carcinology services
Presenter: Nouha Abidi
Session: Poster session 05
1864P - To what extent do nulliparous, female adolescents and young adults diagnosed with cancer have children after cancer treatment?
Presenter: Line Bentsen
Session: Poster session 05
1865P - Women with elderly early-stage breast cancer with type A personality may have decreased self-esteem after chemotherapy: A pilot study (POSEIDON Study)
Presenter: Ozgur Tanriverdi
Session: Poster session 05